PrideRx review
Three approved products routed through the manufacturers' own channels, each with a required monthly membership beside it.
The verdict
PrideRx routes FDA-approved products through LillyDirect and NovoCare, at $149 to $299 in medication, plus a required $99 monthly membership. The all-in figures are $248 for the orals and $398 for the Zepbound pen.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Orforglipron · Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Injection
- From $398/mo
- Oral
- From $248/mo
- Prescription
- Required
- Compounded
- No
PrideRx arranges access to brand orforglipron, brand oral semaglutide and the brand tirzepatide pen, rather than dispensing compounded preparations of its own.
Who writes the prescription, and what do they see?
The membership is what the clinical relationship costs here, and it is stated: $25 for a first month and $99 a month after. What it buys is not described in the same detail as what it costs.
This is a different business from most sellers a reader will meet. The medication comes from the manufacturer's channel at the manufacturer's price, and PrideRx charges for the access and the prescribing around it. That is a clearer separation than a bundled figure, and it means the two charges have to be added.
What happens when the dose goes up?
All three lines are dose-tiered by the manufacturer and the pages say so. Foundayo runs from $149 at the starter dose to $299 at higher ones, and the Zepbound pen from $299 at 2.5 mg to $449 at 7.5 mg and above. A reader escalating pays the manufacturer's ladder plus the same membership throughout.
What the price includes
At the entry doses the all-in figures are $248 a month for either oral and $398 for the Zepbound pen. At the top of the published ladders they become $398 and $548. Six months at the oral entry rate is $1,488 counting the $25 first month. Budgeting from the medication figure alone understates every one of these by $99 a month.
Where it holds up, and where it does not
- Strength: FDA-approved products throughout
- Strength: Manufacturer channels named explicitly
- Strength: Dose ladders published on all three lines
- Strength: The membership is disclosed in writing
- Limitation: A $99 monthly membership is required
- Limitation: The medication figure excludes it
- Limitation: Top doses reach $449 before membership
- Limitation: No state coverage list is recorded
What the evidence says about this kind of treatment
The assessment above is about PrideRx. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants an approved product and has added the membership to the ladder.
- Wrong for
- A reader comparing the medication figure against a compounded all-in price.
The evidence behind what PrideRx prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- What Is Orforglipron? A Daily GLP-1 Tablet That Is Not a Peptide
A small-molecule daily tablet, not a peptide. Over 72 weeks in 3,127 adults, weight fell 11.2% on the top dose against 2.1% on placebo. No trial has compared it against an injection.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How PrideRx compares
| Seller | Who it suits | Go |
|---|---|---|
 NovoCare Pharmacy | Readers who want the approved product and will count thirteen boxes a year rather than twelve | See NovoCare Pharmacy → |
 PeterMD | Readers who want a cancel-anytime subscription and will choose the monthly product over the quarterly offer | See PeterMD → |
 Options Medical Weight Loss | Readers certain of a year who can pay the whole of it at once | See Options Medical Weight Loss → |
More GLP-1 telehealth sellers reviews: altRXAlways Wellness and RecoveryAlyveRxAM RxAmazon One MedicalAmble
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- What does a month really cost?
- $248 for either oral at the entry dose and $398 for the Zepbound pen, because a $99 monthly membership sits on top of the medication figure.
- Are these compounded?
- No. Foundayo and Zepbound come through LillyDirect and the Wegovy Pill through NovoCare, all FDA-approved brand products.
- What happens as my dose rises?
- The manufacturer's ladder applies: Foundayo to $299 and the Zepbound pen to $449 at 7.5 mg and above, with the $99 membership unchanged throughout.
- Is PrideRx expensive compared with other GLP-1 telehealth sellers?
- PrideRx publishes a starting figure of $248/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts PrideRx above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.